Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196

1.

Allopregnanolone and mood disorders.

Bäckström T, Bixo M, Johansson M, Nyberg S, Ossewaarde L, Ragagnin G, Savic I, Strömberg J, Timby E, van Broekhoven F, van Wingen G.

Prog Neurobiol. 2014 Feb;113:88-94. doi: 10.1016/j.pneurobio.2013.07.005. Epub 2013 Aug 23. Review.

PMID:
23978486
2.

Sex steroid induced negative mood may be explained by the paradoxical effect mediated by GABAA modulators.

Andréen L, Nyberg S, Turkmen S, van Wingen G, Fernández G, Bäckström T.

Psychoneuroendocrinology. 2009 Sep;34(8):1121-32. doi: 10.1016/j.psyneuen.2009.02.003. Epub 2009 Mar 9. Review.

PMID:
19272715
3.

Paradoxical effects of GABA-A modulators may explain sex steroid induced negative mood symptoms in some persons.

Bäckström T, Haage D, Löfgren M, Johansson IM, Strömberg J, Nyberg S, Andréen L, Ossewaarde L, van Wingen GA, Turkmen S, Bengtsson SK.

Neuroscience. 2011 Sep 15;191:46-54. doi: 10.1016/j.neuroscience.2011.03.061. Epub 2011 May 13. Review.

PMID:
21600269
4.

GABAA Receptor-Modulating Steroids in Relation to Women's Behavioral Health.

Bäckström T, Bixo M, Strömberg J.

Curr Psychiatry Rep. 2015 Nov;17(11):92. doi: 10.1007/s11920-015-0627-4. Review.

PMID:
26396092
5.

Women with premenstrual dysphoric disorder have altered sensitivity to allopregnanolone over the menstrual cycle compared to controls-a pilot study.

Timby E, Bäckström T, Nyberg S, Stenlund H, Wihlbäck AC, Bixo M.

Psychopharmacology (Berl). 2016 Jun;233(11):2109-17. doi: 10.1007/s00213-016-4258-1. Epub 2016 Mar 10.

PMID:
26960697
6.

Pathogenesis in menstrual cycle-linked CNS disorders.

Bäckström T, Andersson A, Andreé L, Birzniece V, Bixo M, Björn I, Haage D, Isaksson M, Johansson IM, Lindblad C, Lundgren P, Nyberg S, Odmark IS, Strömberg J, Sundström-Poromaa I, Turkmen S, Wahlström G, Wang M, Wihlbäck AC, Zhu D, Zingmark E.

Ann N Y Acad Sci. 2003 Dec;1007:42-53. Review.

PMID:
14993039
7.

Action by and sensitivity to neuroactive steroids in menstrual cycle related CNS disorders.

N-Wihlbäck AC, Sundström-Poromaa I, Bäckström T.

Psychopharmacology (Berl). 2006 Jun;186(3):388-401. Epub 2005 Dec 15. Review.

PMID:
16362406
8.

Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder.

Girdler SS, Straneva PA, Light KC, Pedersen CA, Morrow AL.

Biol Psychiatry. 2001 May 1;49(9):788-97.

PMID:
11331087
9.

Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study.

Epperson CN, Haga K, Mason GF, Sellers E, Gueorguieva R, Zhang W, Weiss E, Rothman DL, Krystal JH.

Arch Gen Psychiatry. 2002 Sep;59(9):851-8.

PMID:
12215085
10.

Relationship between allopregnanolone and negative mood in postmenopausal women taking sequential hormone replacement therapy with vaginal progesterone.

Andréen L, Sundström-Poromaa I, Bixo M, Andersson A, Nyberg S, Bäckström T.

Psychoneuroendocrinology. 2005 Feb;30(2):212-24.

PMID:
15471618
11.

Allopregnanolone has no effect on startle response and prepulse inhibition of startle response in patients with premenstrual dysphoric disorder or healthy controls.

Kask K, Bäckström T, Lundgren P, Sundström Poromaa I.

Pharmacol Biochem Behav. 2009 Jun;92(4):608-13. doi: 10.1016/j.pbb.2009.02.014. Epub 2009 Mar 4.

PMID:
19268499
12.

5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder.

Martinez PE, Rubinow DR, Nieman LK, Koziol DE, Morrow AL, Schiller CE, Cintron D, Thompson KD, Khine KK, Schmidt PJ.

Neuropsychopharmacology. 2016 Mar;41(4):1093-102. doi: 10.1038/npp.2015.246. Epub 2013 Aug 14.

13.

The effect of a low dose of alcohol on allopregnanolone serum concentrations across the menstrual cycle in women with severe premenstrual syndrome and controls.

Nyberg S, Andersson A, Zingmark E, Wahlström G, Bäckström T, Sundström-Poromaa I.

Psychoneuroendocrinology. 2005 Oct;30(9):892-901.

PMID:
15979810
14.

Progesterone metabolite allopregnanolone in women with premenstrual syndrome.

Rapkin AJ, Morgan M, Goldman L, Brann DW, Simone D, Mahesh VB.

Obstet Gynecol. 1997 Nov;90(5):709-14.

PMID:
9351749
15.

Premenstrual dysphoric disorder and prefrontal reactivity during anticipation of emotional stimuli.

Gingnell M, Bannbers E, Wikström J, Fredrikson M, Sundström-Poromaa I.

Eur Neuropsychopharmacol. 2013 Nov;23(11):1474-83. doi: 10.1016/j.euroneuro.2013.08.002. Epub 2013 Aug 17.

PMID:
24001875
16.

Increased neurosteroid sensitivity--an explanation to symptoms associated with chronic work related stress in women?

Bäckström T, Bixo M, Nyberg S, Savic I.

Psychoneuroendocrinology. 2013 Jul;38(7):1078-89. doi: 10.1016/j.psyneuen.2012.10.014. Epub 2012 Nov 22.

PMID:
23177572
17.

Treatment of premenstrual dysphoric disorder with the GABAA receptor modulating steroid antagonist Sepranolone (UC1010)-A randomized controlled trial.

Bixo M, Ekberg K, Poromaa IS, Hirschberg AL, Jonasson AF, Andréen L, Timby E, Wulff M, Ehrenborg A, Bäckström T.

Psychoneuroendocrinology. 2017 Jun;80:46-55. doi: 10.1016/j.psyneuen.2017.02.031. Epub 2017 Mar 1.

18.

Tolerance to allopregnanolone with focus on the GABA-A receptor.

Turkmen S, Backstrom T, Wahlstrom G, Andreen L, Johansson IM.

Br J Pharmacol. 2011 Jan;162(2):311-27. doi: 10.1111/j.1476-5381.2010.01059.x. Review.

19.

Reduced benzodiazepine sensitivity in patients with premenstrual syndrome: a pilot study.

Sundström I, Ashbrook D, Bäckström T.

Psychoneuroendocrinology. 1997 Jan;22(1):25-38.

PMID:
9141149
20.

Neuroactive steroid effects on cognitive functions with a focus on the serotonin and GABA systems.

Birzniece V, Bäckström T, Johansson IM, Lindblad C, Lundgren P, Löfgren M, Olsson T, Ragagnin G, Taube M, Turkmen S, Wahlström G, Wang MD, Wihlbäck AC, Zhu D.

Brain Res Rev. 2006 Aug;51(2):212-39. Epub 2005 Dec 20. Review.

PMID:
16368148

Supplemental Content

Support Center